2rgu
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | [[Image:2rgu. | + | {{Seed}} |
+ | [[Image:2rgu.png|left|200px]] | ||
<!-- | <!-- | ||
Line 9: | Line 10: | ||
{{STRUCTURE_2rgu| PDB=2rgu | SCENE= }} | {{STRUCTURE_2rgu| PDB=2rgu | SCENE= }} | ||
- | + | ===Crystal structure of complex of human DPP4 and inhibitor=== | |
- | + | <!-- | |
- | + | The line below this paragraph, {{ABSTRACT_PUBMED_18052023}}, adds the Publication Abstract to the page | |
+ | (as it appears on PubMed at http://www.pubmed.gov), where 18052023 is the PubMed ID number. | ||
+ | --> | ||
+ | {{ABSTRACT_PUBMED_18052023}} | ||
==About this Structure== | ==About this Structure== | ||
Line 37: | Line 41: | ||
[[Category: Signal-anchor]] | [[Category: Signal-anchor]] | ||
[[Category: Transmembrane]] | [[Category: Transmembrane]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | |
+ | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 15:07:11 2008'' |
Revision as of 12:07, 29 July 2008
Crystal structure of complex of human DPP4 and inhibitor
Template:ABSTRACT PUBMED 18052023
About this Structure
2RGU is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
8-(3-(R)-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin -2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes., Eckhardt M, Langkopf E, Mark M, Tadayyon M, Thomas L, Nar H, Pfrengle W, Guth B, Lotz R, Sieger P, Fuchs H, Himmelsbach F, J Med Chem. 2007 Dec 27;50(26):6450-3. Epub 2007 Dec 1. PMID:18052023
Page seeded by OCA on Tue Jul 29 15:07:11 2008